Skip to main content
News Mass 12.2021
© Volker Lannert / Uni Bonn

News categories: Honors & Funding

Elvira Mass selected as EMBO Young Investigator junior scientist

Prof. Elvira Mass, developmental biologist at the LIMES Institute of the University of Bonn and member of the Cluster of Excellence ImmunoSensation2, will join the EMBO Young Investigator Program on 01.01.2022.

The EMBO Young Investigator Program supports selected young European scientists with outstanding achievements in the field of life sciences. The award is linked to a financial support of 15,000 €, which can be extended by up to 10,000 € per year. Prof. Elvira Mass and her team study the development and function of resident macrophages - phagocytes that are present in almost every tissue and, as part of the innate immune system, are an important part of the body's defense system.

Macrophages form the first line of defense against pathogens by ingesting them and breaking them down into their components (antigens). They present these antigens to other cells of the immune system and produce cytokines, which elicits an adapted immune response. According to recent scientific findings, however, resident macrophages have more tasks than previously thought: Beyond their classical role as scavenger cells, resident macrophages most likely significantly contribute to organ development. The team led by Prof. Elvira Mass investigates the function of resident macrophages in brain development. For this purpose, she recently received an ERC Starting Grant to investigate potential hazards of nanoplastics ingested with the food. The aim is to clarify whether the nanoplastic reaches our organs, whether it is taken up there, especially by macrophages, and whether it can induce or contribute to the development of neurological diseases in the long term (read more) .

However, the paradigm shift in the field of resident macrophages does not only apply to the function, but also to the origin of the phagocytes. Resident macrophages have been shown to develop in many organs during embryonic development and to self-renew in adult tissues under homeostatic conditions. Prof. Elvira Mass's team is interested in understanding the contribution of resident macrophages to homeostatic function during organ development, but also in the process of various disease conditions such as obesity or infectious diseases.

Born in present-day Kazakhstan, the Russian-German earned her PhD in Molecular Biomedicine at the University of Bonn, Germany, and returned to her alma mater after a three-year research stay at King's College London and Memorial Sloan-Kettering Cancer Center in New York. In 2017, she started the research group Developmental Biology of the Innate Immune System at LIMES Institute. In 2019, Elvira Mass was appointed W2 Professor at the University of Erlangen-Nürnberg, but was reappointed to the University of Bonn in 2020.

The scientific environment at the LIMES Institute and the Cluster of Excellence ImmunoSensation2 at the University of Bonn offers Prof. Elvira Mass an optimal environment for her research. This is based on the common scientific focus of the researchers at LIMES and other institutes united in the Cluster of Excellence ImmunoSensation2, as well as the connection to several national international research networks. With the EMBO Young Investigator award, this environment is now extended by a renowned network. In addition to direct financial support, Prof. Elvira Mass and her team will also benefit from training and mentoring opportunities linked to the award over the next 4 years.


Contact

Prof. Dr. Elvira Mass

Life & Medical Sciences Institute (Limes)

University of Bonn

Carl-Troll-Strasse 31

53115 Bonn

emass(at)uni-bonn.de

Related news

Gut

News categories: Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry

Back to the news overview